Prospective cohort investigation reveals significant enhancements in eyelid position and patient-reported outcomes following topical oxymetazoline administration.
Key Points
Topical oxymetazoline significantly improved eyelid position and aesthetic outcomes at 15 minutes post-administration.
Participants showed a mean increase of 0.8 mm in both margin reflex distance-1 and palpebral fissure height after treatment.
85% of participants reported 51% or higher outcome satisfaction, indicating strong acceptance of the treatment.
No treatment-associated adverse events were reported, confirming safety during the investigation.